Veradermics, Incorporated

MANE·NYSE·Healthcare
Compare
122.40−8.50 (−6.49%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours122.400.00 (0.00%)Oct 12, 4:39 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close130.90
Open129.99
Day range120.57129.93
52-week range32.00136.72
Off day high−5.80%
Off 52-week high−10.47%
Volume991.21K
Avg. volume (3M)791.32K
Market cap5.11B
EPS (TTM)-4.24
Forward P/E-45.55
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding41.78M
Short interest15.60% of float
Earnings dateAug 11, 2026 (est.)
Analyst target163.50
Profit margin0.00%

Against its peers

Compare in full ›
MANE KRYS VRCA PVLA TARS PTGX
Market cap 5.11B 9.83B 68.89M 1.94B 3.48B 9.37B
P/E (TTM) — 41.6 — — — 140.7
Forward P/E -45.6 35.8 -2.7 -17.9 -206.7 -727.5
Price/book 6.3 7.2 16.0 8.9 9.3 11.1
Dividend yield — — — — — —
1-year change +246.75% +79.50% +0.24% +82.07% +4.01% +81.55%
Today −6.49% +0.14% −2.43% −3.16% +1.69% +0.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All MANE news ›
MarketBeat·Negative

Veradermics (NYSE:MANE) Stock Falls 8.1% - Here's What Happened

Veradermics, Incorporated (NYSE:MANE - Get Free Report) fell 8.1% during mid-day trading on Tuesday. The stock traded as low as $110.13 and last traded at $109.2560. Approximately 523,982 shares changed hands during trading, a decline of…

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.